This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Codiak Biosciences, Inc.. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Innovations by Jonas Andrej Nilsson
Introduction
Jonas Andrej Nilsson is a notable inventor based in Kållered, Sweden. He has made significant contributions to the field of therapeutic agents, particularly in the development of nanovesicles for targeted delivery. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.
Latest Patents
Jonas's latest patents focus on a method of producing nanovesicles that comprise an oligonucleotide inhibitor targeting oncogenes or proto-oncogenes. The method involves introducing a DNA sequence encoding an oligonucleotide capable of inhibiting a human oncogenic or proto-oncogenic transcription factor into a mammalian cell. The process allows the cell to express the inhibitor oligonucleotide, which is then obtained from the cell in the form of nanovesicles. These nanovesicles can be effectively and specifically targeted to cancer cells, facilitating the delivery of the inhibitor oligonucleotide.
Career Highlights
Jonas is currently associated with Codiak Biosciences, Inc., where he continues to innovate in the field of biotechnology. His work is instrumental in developing new therapeutic strategies that can potentially improve patient outcomes in cancer treatment.
Collaborations
Jonas collaborates with Jan Lötvall, a fellow researcher, to further enhance the impact of their work in the field of nanotechnology and therapeutic delivery systems.
Conclusion
Jonas Andrej Nilsson's contributions to the field of therapeutic agents through his innovative patents highlight the importance of targeted delivery systems in modern medicine. His work at Codiak Biosciences, Inc. continues to inspire advancements in cancer treatment.